Archives
-
Baicalin and Adult Cortical Plasticity: Assay Lessons
2026-09-24
Baicalin reactivated ocular dominance plasticity in an adult mouse amblyopia model, offering a useful case study in how to connect neural activity, inhibitory markers, and functional recovery. This article examines the study’s experimental logic, its limits, and practical considerations for research use.
-
Oleanolic Acid: From Liposome Metrics to Biology
2026-09-23
Oleanolic acid research depends on more than measuring how much compound enters a liposome. This article explains how to interpret encapsulation data, choose fit-for-purpose analytical methods, and connect delivery measurements cautiously to immune and antiviral research.
-
BI-1347 Inhibitor: CDK8/19 Translation
2026-09-23
BI-1347 offers translational researchers a selective small-molecule starting point for testing target-dependent signaling and antitumor biology. This article connects its research-use profile with a 2026 Bone Research study of CDK8/19 inhibition in osteoarthritis, while distinguishing study-derived evidence from product specifications and proposed workflows.
-
3X FLAG Peptide for Mechanistic Protein Assays
2026-09-22
The 3X (DYKDDDDK) Peptide can do more than improve signal: it helps connect protein recovery, immunodetection, and structural validation in mechanistic workflows. This guide integrates FLAG assay design with lessons from nimbolide chemoproteomics and provides practical controls for metal-sensitive experiments.
-
Cerulenin Reveals How Leucomycin Is Biosynthesized
2026-09-21
The 1977 study by Takeshima, Kitao, and Omura used cerulenin to show that Leucomycin biosynthesis in Streptomyces kitasatoensis depends on a fatty-acid-like condensation process. Its combination of reversible inhibition, radiolabeled acetate tracing, and macromolecular synthesis controls provided early functional evidence for a polyketide origin of the macrolide aglycone.
-
FLAG tag Peptide: From Purification to Mechanism
2026-09-21
A translational guide to using the FLAG tag Peptide (DYKDDDDK) as more than a detection reagent: a controllable bridge between recombinant protein production, biochemical validation, and mechanistic interpretation.
-
EZH2 Inhibition Restrains SAHA-Induced SASP in SCLC
2026-09-18
The Cell Death Discovery study links SAHA-induced senescence in small cell lung cancer cells to cytoplasmic chromatin fragments, Tpr-dependent nuclear changes, and cGAS-STING activation. Its central advance is showing that EZH2 inhibition can reduce this inflammatory secretory program while strengthening SAHA-mediated growth suppression, suggesting a strategy to separate therapeutic senescence from tumor-promoting SASP.
-
Aminopeptidase Inhibitors in Cancer Therapy
2026-09-18
Hitzerd and colleagues position aminopeptidases as actionable nodes downstream of the ubiquitin–proteasome system and explain why their inhibitors may complement anticancer treatment. The review’s main practical contribution is a framework linking enzyme localization, substrate processing, inhibitor exposure, combination therapy, and resistance biology rather than treating aminopeptidase inhibition as a single-target strategy.
-
Nitrocefin Workflows for β-Lactamase Assays
2026-09-17
Nitrocefin converts β-lactamase activity into a rapid yellow-to-red signal, making it useful for resistance profiling, enzyme kinetics, and inhibitor screening. This workflow connects practical assay design with the peptide-discovery strategy reported for TEM-1 β-lactamase, helping researchers move computational hits toward experimental validation.
-
Phosphotungstic Acid Negative Stain: EM Workflow
2026-09-16
Use Phosphotungstic Acid Negative Stain Solution for rapid, high-contrast imaging of viruses, macromolecules, bacteria, and other specimens. This workflow connects structural screening with coronavirus entry research while clearly separating visible morphology from glycan-specific biochemical conclusions.
-
Selective Autophagy Tunes IRF3 and IFN Responses
2026-09-15
Wu et al. show that CALCOCO2/NDP52-mediated selective autophagy degrades IRF3 in a virus-load-dependent manner, while PSMD14 preserves basal IRF3 by removing K27-linked ubiquitin chains. The study defines a regulatory circuit that balances antiviral type I interferon production with immune suppression and clarifies how ubiquitin editing intersects with autophagic clearance.
-
Luminescent ATP Cell Viability Assay Kit I
2026-09-15
The Luminescent ATP Cell Viability Assay Kit I uses ATP-dependent firefly luciferase luminescence detection for rapid, sensitive cell viability measurement. Its reported 10 to 30,000-cell linear range and detection as early as 10 minutes support cytotoxicity, proliferation, and ferroptosis studies, while the ATP endpoint does not by itself identify a specific death mechanism.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflows
2026-09-14
Build a quantitative delivery assay that separates cellular uptake from productive translation in the same experiment. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 tracking, EGFP functional reporting, Cap1 architecture, and 5-moUTP modification for nanoparticle, electroporation, and macrophage-focused optimization.
-
Vasopressin Analogues: Evidence, Design, and Translation
2026-09-13
The reference review explains how vasopressin biology can be reshaped through receptor-selective, stability-enhancing, and longer-acting analogues. Its comparison of lypressin, desmopressin, terlipressin, and related peptides clarifies opportunities and limitations spanning diabetes insipidus, vasoconstriction research, and emerging antiviral investigation.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-12
Zhao and colleagues describe a standardized fresh whole-blood stimulation protocol that combines pathogen-relevant immune challenges with pharmacological modulation of cellular metabolism. By linking defined perturbations to cytokine outputs while preserving blood-system complexity, the method supports more reproducible cohort-scale studies of immunometabolic regulation.